Healthcare
China Evergrande New Energy Vehicle Group Limited(EVGRF)
Live Price
Offline$0.0002
+0.00% today
1Y Change
-98.18%
Window
Jun 25, 2025 → Jun 19, 2026
- Market Cap
- $1.60B
- Revenue Growth
- +900.0%
- EPS Growth
- +19.7%
- Dividend Yield
- 0.0%
Coverage: 251 bars · Jun 25, 2025 → Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
China Evergrande New Energy Vehicle Group Limited (EVGRF) is a Healthcare stock with a market cap of $1.60B and listed on OTC. The stock last traded around $0.00 and down 98.2% across the available one-year price window (Jun 25, 2025 → Jun 19, 2026). Baseline metrics include revenue growth of +900.0%, EPS growth of +19.7%, a dividend yield of 0.0%. What stands out right now is revenue +900.0%, EPS +19.7%, free cash flow +70.8% with operating margin -668.7% and ROIC 108.1%. Valuation is more restrained than many high-expectation growth names at price/sales 1.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines EVGRF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+900.0% vs +7.6% peer median
Operating Margin
Below sector median
-668.7% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +900.0% and EPS at +19.7%, with operating margin around -668.7%.
Benchmark Edge
EVGRF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EVGRF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EVGRF Max Drawdown
-98.18%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for EVGRF and SPY.
Company Overview
China Evergrande New Energy Vehicle Group Limited
Other OTC
China Evergrande New Energy Vehicle Group Limited, an investment holding company, operates as a health management company in the People's Republic of China, Europe, and internationally. The company operates through two segments, Health Management and New Energy Vehicle. It develops and sells health and living properties; and provides community health management, medical cosmetology, and anti-aging services, as well as elderly care and rehabilitation. The company is involved in the wholesale of home care and healthcare products, as well as provision of healthcare services and software services. In addition, it engages in the research and development of pharmaceuticals; production of medical equipment; and manufacture and sale of smart mobility and lithium-ion battery. Further, the company is involved in the research, development, production, and sales of new energy vehicles and vehicle living project. The company was formerly known as Evergrande Health Industry Group Limited and changed its name to China Evergrande New Energy Vehicle Group Limited in August 2020. China Evergrande New Energy Vehicle Group Limited was founded in 1999 and is headquartered in Guangzhou, China. China Evergrande New Energy Vehicle Group Limited is a subsidiary of China Evergrande Group.
- Leadership
- Shawn Siu
- IPO Date
- Feb 1, 2021
- Employees
- 829
- Street Address
- Evergrande International Center
- Mailing
- Guangzhou, 510620
- Region
- Guangzhou, CN
- Reporting Currency
- USD
- Investor Line
- +852 2287 9208
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 1.2
- Price/Book
- —
Growth
- Revenue
- +900.0%
- EPS
- +19.7%
- Free Cash Flow
- +70.8%
Profitability
- Gross Margin
- -3.8%
- Operating Margin
- -668.7%
- Net Margin
- -890.5%
- ROE
- 20.8%
- ROIC
- 108.1%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.34
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.